Complex Myeloma Diagnosis Program | Asklepios Clinic St. Georg

The myeloma diagnosis program at Asklepios Clinic St. Georg is an internationally recognized diagnostic track designed to rapidly and definitively identify plasma cell disorders. Managed within the Haematology-Oncology Centre, this program utilizes a "maximum-care" infrastructure to move patients from initial suspicion to a confirmed molecular staging. The program is led by world-class specialists Prof. Dr. Ahmet Elmaagacli and Dr. Hans Salwender, who utilize the clinic’s specialized in-house laboratories to bypass the delays associated with external testing. The program follows the latest International Myeloma Working Group criteria, focusing on identifying the disease before significant end-organ damage (CRAB symptoms) occurs. A key feature of the St. Georg program is the Interdisciplinary tumor board. Every complex diagnosis is reviewed by a panel of hematologists, radiologists, and pathologists to ensure no diagnostic detail is overlooked. This makes the offer a global magnet for patients seeking a validated second opinion when initial tests are inconclusive or when another diagnosis needs to be distinguished from active multiple myeloma. The diagnostic results serve as the foundation for the clinic’s world-renowned treatment wing, which specializes in autologous stem cell transplantation and high-intensity induction therapies. By providing a "single-source" diagnostic-to-treatment path, Asklepios St. Georg ensures that international patients receive a seamless, high-speed medical experience in one of Germany's most advanced hematological centers.